Quantcast
Last updated on April 23, 2014 at 21:24 EDT
Silly Putty Ingredient Could Help Stem Cells Become Motor

Silly Putty Ingredient Could Help Stem Cells Become Motor Neurons

redOrbit Staff & Wire Reports - Your Universe Online An ingredient found in Silly Putty could help scientists more efficiently turn human embryonic stem cells into fully functional specialized cells, according to research published online...

Latest ALS Stories

2014-04-07 08:32:26

Will Also Present Update on Ongoing Phase II Trial ROCKVILLE, Md., April 7, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Eva Feldman, PhD, MD, principal investigator of Neuralstem's NSI-566 stem cell trial in ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease) will present Phase I data at the Keystone Symposia, "Engineering Cell Fate and Function," in Olympic Valley, California, on April 9(th...

2014-04-04 12:27:33

By studying nerve cells that originated in patients with a severe neurological disease, a University of Wisconsin-Madison researcher has pinpointed an error in protein formation that could be the root of amyotrophic lateral sclerosis. Also called Lou Gehrig's disease, ALS causes paralysis and death. According to the ALS Association, as many as 30,000 Americans are living with ALS. After a genetic mutation was discovered in a small group of ALS patients, scientists transferred that gene...

2014-04-01 16:25:56

EHE International Donates Window Display to Augie's Quest to Raise Awareness of ALS and Promote Participation in Funding Research for Treatments and a Cure CAMBRIDGE, Mass., April 1, 2014 /PRNewswire/ -- During the month of April, Zumba® Fitness' campaign benefiting Augie's Quest, "Together We Dance(TM) to Cure ALS," will be featured in a window display in Rockefeller Center. Augie's Quest is a fundraising initiative that supports the nonprofit, ALS Therapy Development Institute...

2014-03-31 12:29:17

WASHINGTON, March 31, 2014 /PRNewswire-USNewswire/ -- In work supported by The ALS Association, researchers have discovered a new ALS-causing gene and have linked its function to that of another prominent disease gene. The study was published in the journal Nature Neuroscience. http://photos.prnewswire.com/prnvar/20131211/MM32178LOGO ALS (amyotrophic lateral sclerosis), otherwise known as Lou Gehrig's Disease, is a progressive neurodegenerative disease that affects neurons (nerve...

2014-03-24 20:23:30

In the news release, Antioxidant Shows Promise in Supporting Treatment for Lou Gehrig's Disease, issued 24-Mar-2014 over PR Newswire, we are advised by the company that the source being attributed should be "The Center of Free Radical and Biomedical Research" rather than "MitoQ Limited"; and the headline should read "Antioxidant Shows Promise in Fight Against Lou Gehrig's Disease" rather than "Antioxidant Shows Promise in Supporting Treatment for Lou Gehrig's Disease" as originally issued...

2014-03-24 08:27:10

MONTEVIDEO, Uruguay, March 24, 2014 /PRNewswire/ -- Researchers at The Center of Free Radical and Biomedical Research at Facultad de Medicina, Universidad de la Republica in Uruguay today announced the discovery that the antioxidant MitoQ prolonged the lifespan and health-span of mice suffering from amyotrophic lateral sclerosis-like (ALS) disease, and successfully improved functional parameters related to muscular strength and reversed mitochondrial damage in nervous and muscle...

2014-03-17 08:28:00

ROCKVILLE, Md., March 17, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that the final results from the Phase I safety trial using NSI-566 spinal cord stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) were published in the peer-reviewed journal, "Annals of Neurology" http://onlinelibrary.wiley.com/doi/10.1002/ana.24113/full. In "Intraspinal Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis: Phase I Trial...

2014-03-12 12:28:51

YARDLEY, Pa., March 12, 2014 /PRNewswire/ -- Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a progressive neurological disease that affects nerve cells in the brain and spinal cord of humans. The limited treatment options available, and fatal nature of ALS, have made the need for novel research approaches urgent. http://photos.prnewswire.com/prnvar/20140206/NE60551LOGO Dogs Go to Bat Against Lou Gehrig's Disease examines how veterinary researchers are studying a...

2014-03-10 16:32:46

BALTIMORE, Md., March 10, 2014 /PRNewswire-USNewswire/ -- With the opening of the 14(th) Annual Robert Packard Center for ALS Research Symposium, the Packard Center and The ALS Association are pleased to announce the first scientific grant award from the Winokur Family Research Initiative. The inaugural grant will help to fund a project under the direction on Phil Wong, Ph.D., a Professor of Pathology at Johns Hopkins University and Liam Chen, M.D., Ph.D., Assistant Professor of...

2014-03-10 08:31:05

ROCKVILLE, Md., March 10, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today provided an update on its clinical trials program and reported its 2013 financial results for the year ended December 31, 2013. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO) "2013 was an exciting year for advancement in our NSI-566 cell therapy clinical programs," said Karl Johe, PhD, Neuralstem's Chairman of the Board and Chief Scientific Officer. "Our Phase II ALS trial...